Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergoogle.co.in
Google Alert - omalizumab
Get the latest updates from Google Alert - omalizumab directly as they happen.
Follow now 112 followers
Latest posts
Last updated about 3 hours ago
Omlyclo : un biosimilaire d'omalizumab disponible en officine - Pharma 365
about 11 hours ago
Commercialisé en France depuis octobre 2025, Omlyclo® (Celltrion Healthcare) est le premier...
Excellergy strebt in den IgE-Therapiemarkt mit innovativen Ansätzen - it boltwise
about 13 hours ago
... Omalizumab-Antikörper im Vergleich zu herkömmlichem Omalizumab. Diese Ergebnisse deuten darauf hin...
Excellergy to Begin Phase I Trials for New IgE Therapy as Xolair Patent Nears Expiry
about 13 hours ago
The company's efforts come as Xolair (omalizumab), a widely used IgE-targeting therapy...
Guggenheim inicia cobertura de Rapt Therapeutics con calificación de Compra por ...
about 13 hours ago
... omalizumab. El anuncio de la oferta pública provocó una caída del...
Excellergy eyes IgE therapy space as Xolair nears patent expiry
about 13 hours ago
... omalizumab antibodies, so-called ECRIs, versus wildtype omalizumab. The in vitro results...
omalizumab as a therapeutic strategy for asthma and cow's milk allergy - Termedia
about 16 hours ago
Linking IgE and mast cells in pediatric allergic multimorbidity: omalizumab as a...
omalizumab as a therapeutic strategy for asthma and cow's milk allergy - Termedia
about 16 hours ago
Further research is needed to optimize treatment strategies for pediatric allergic multimorbidity...
Omalizumab y vacunas vivas | Comité Asesor de Vacunas de la AEP
2 days ago
Omalizumab es un anticuerpo monoclonal específico que bloquea la unión de la...
Evolving Treatment Landscape for Chronic Spontaneous - GlobeNewswire
3 days ago
While Genentech/Novartis' Xolair® (omalizumab) continues to hold the dominant position in the...
Executive Insights: What's Next For Roche?
4 days ago
On a product basis, the company reported that its top five growth...
Celltrion to expand global partnerships at CPHI Worldwide 2025 in Frankfurt - KBR
4 days ago
... omalizumab-igec) for dermatologic conditions. The company said it will continue to...